Schedule 13D ownership disclosure
Acer Therapeutics Inc.
Security class unavailable · CUSIP: 00444P108
Event date: 2022-11-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-297521
- Form type
- SC 13D
- Filer
- Acer Therapeutics Inc.
- CIK
- CIK 1069308
- Filed
- Dec 02, 2022
- Reporting period
- Nov 29, 2022
- Description
- Schedule 13D beneficial ownership